Connect with us
European Gaming Congress 2024

Artificial Intelligence

BYND Cannasoft Provides EZ-G Device Milestones for the Second Half of 2023

Published

on

ASHKELON, Israel and VANCOUVER, British Columbia, July 25, 2023 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company“) today announced several milestones for the second half of 2023 on the development of its groundbreaking EZ-G Device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, could enhance therapeutic approaches for women’s health issues by offering cutting-edge technology to cater to the evolving needs of consumers. Moreover, the company is actively negotiating with synergistic businesses, particularly those in the CBD oils sector, for a transformative transaction. 

BYND Cannasoft is pleased to provide the following key milestones in the development of the EZ-G Device:

  1. Finishing the Prototype of the EZ-G Device in 60 Days: BYND Cannasoft plans to reiterate its commitment to innovation by accomplishing the development of the EZ-G Device’s initial prototype within a 60-day timeline. The Company’s team of experts intends to create a prototype that showcases the technology’s potential to disrupt the market.
  2. EZ-G Device Focus Group Experience within 60 Days: In line with BYND Cannasoft’s customer-centric approach, the Company plans to engage a focus group to perform rigorous testing and evaluation of the EZ-G Device over the next 60 days. This process will provide valuable insights and user feedback, helping to refine the product to exceed customer expectations. 
  3. Finalizing the EZ-G Device Prototype and Software by the End of the Fourth Quarter: Building upon insights gained from the focus group, BYND Cannasoft intends to build on its recent successful completion of the laboratory testing phase by fine-tuning the EZ-G Device’s prototype and software. The Company is dedicated to refining user experience and functionality to introduce a superior product. 
  4. Going to Market with the EZ-G Device in the First Quarter of 2024: With a meticulously developed and thoroughly tested product, BYND Cannasoft’s management believes the Company is on track for a market launch of the EZ-G Device in the first quarter of 2024. The Company anticipates that the product will set new industry benchmarks. 

Yftah Ben Yaackov, CEO and Director of BYND Cannasoft said, “As part of the prototype development of the EZ-G device, numerous comprehensive experiments were conducted during the recent laboratory testing phase to assess the functionality and performance of the assembled sensors within the device that are capable of detecting indicators such as temperature, heart rate, contractions, and fluids. Our next phase will include completing the prototype, engaging in feedback from various focus groups, and solidifying strategic agreements to bring the EZ-G Device to market.” Mr. Ben Yaackov continued, “This is an excellent example of our commitment to delivering exceptional products and experiences to our customers. Our relentless focus on innovation and customer satisfaction continues to drive our success, positioning BYND Cannasoft as a trailblazer in the women’s health industry.”

In addition to these groundbreaking milestones, BYND Cannasoft is actively negotiating with several companies with synergistic business models, particularly those in the CBD oils sector. These discussions aim to establish transformative partnerships, opening doors for new opportunities and amplifying the impact of both companies in the market. 

About BYND Cannasoft Enterprises Inc.

BYND Cannasoft Enterprises is an Israeli-based integrated software and cannabis company. BYND Cannasoft owns and markets “Benefit CRM,” a proprietary customer relationship management (CRM) software product enabling small and medium‐sized businesses to optimize their day‐to‐day business activities such as sales management, personnel management, marketing, call center activities, and asset management. Building on our 20 years of experience in CRM software, BYND Cannasoft is developing an innovative new CRM platform to serve the needs of the medical cannabis industry by making it a more organized, accessible, and price-transparent market. The Cannabis CRM System will include a Job Management (BENEFIT) and a module system (CANNASOFT) for managing farms and greenhouses with varied crops. BYND Cannasoft owns the patent-pending intellectual property for the EZ-G device. This therapeutic device uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women’s health issues. The EZ-G device includes technological advancements as a sex toy with a more realistic experience and the prototype utilizes sensors to determine what enhances the users’ pleasure. The user can control the device through a Bluetooth app installed on a smartphone or other portable device. The data will be transmitted and received from the device to and from the secure cloud using artificial intelligence (AI). The data is combined with other antonymic user preferences to improve its operation by increasing sexual satisfaction.

Advertisement
Stake.com

For Further Information please refer to information available on the Company’s website: www.cannasoft-crm.com, the CSE’s website: www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-inc and on SEDAR: www.sedar.com.

Gabi Kabazo
Chief Financial Officer
Tel: (604) 833-6820
e‐mail: [email protected]

For Media and Investor Relations, please contact:

David L. Kugelman
(866) 692-6847 Toll Free – U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
[email protected]
Skype: kugsusa

Cautionary Note Regarding Forward-Looking Statements

Advertisement
Stake.com

This press release includes certain statements that may be deemed “forward-looking statements” including statements regarding the filing of a final Prospectus. All statements in this release, other than statements of historical facts, that address future events or developments that the Company expects, are forward-looking statements including but not limited to intended business objectives and the expected timelines to accomplish those objectives. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company’s current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including unanticipated regulatory requests and delays, final patents approval, and those factors discussed in filings made by the company with the Canadian securities regulatory authorities, including (without limitation) in the company’s management’s discussion and analysis for the year ended December 31, 2022 and annual information form dated March 31, 2023, which are available under the company’s profile at www.sedar.com, and in the Company’s Annual Report on Form 20-F for the year then ended that was filed with the U.S. Securities and Exchange Commission on April 27, 2023. Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward‐looking statements, except as required by law. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forward‐looking statements.

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Scorpios’ Summer Cultural Series Redefines AI & Visual Art in Mykonos & Bodrum

Published

on

scorpios’-summer-cultural-series-redefines-ai-&-visual-art-in-mykonos-&-bodrum

LONDON, July 3, 2024 /PRNewswire/ — Scorpios, the renowned beach concept and creative gathering place, in partnership with art tech pioneers HOFA Gallery, announces ‘Evolving Perspectives’ the second edition of their Encounters summer arts programme. Running from 18 July to 18 September, this 9-week series expands to take place across Scorpios’ two stunning beachfront locations, Mykonos and the newly opened Bodrum.  Featuring immersive installations and live music performances, the programme will showcase AI and visual artists, headlined by Joseph Klibansky, Random International, and Sougwen Chung – all revered for pushing the boundaries of art and technology.

Building on the success of 2023’s inaugural edition launched with Turkish AI artist and director Refik Anadol, his special collaboration with the Yawanawa Indigenous communities of Brazil’s Amazon, was regarded as a profound exploration of the relationship between human consciousness and nature. Over half a million people attended last year’s programme, generating $3 million in artwork sales, with Refik Anadol’s Yawanawa heritage project alone selling out in hours and raising $1.5 million for the preservation campaign. 
HOFA Co-founder Elio D’Anna says: “The 2023 season of Encounters was a groundbreaking and very successful programme that brought together AI and digital artists, musicians, and an audience of global changemakers and creatives through a series of live performances and installations. 
“This year’s ‘Evolving Perspectives’ programme continues to push boundaries, making it the most exciting synchronisation of visual art and cultural engagement, while also delivering a very powerful message on the power of AI and human-machine collaboration to help us achieve a more harmonious coexistence with nature.” 
The Mykonos lineup headlines Dutch contemporary artist Joseph Klibansky from 18-21 July 2024. Celebrated for his innovative use of technology in art and sculpture, will present ‘Tree of Life’ merging digital art with environmental stewardship. This collection creates a unified visual narrative rich in depth and storytelling, featuring intricate patterns and vibrant colours inspired by nature. The new ‘Tree of Life’ collection includes a large-scale video sculpture installation to be exhibited at Scorpios Mykonos, along with 1,000 unique digitally painted fine art prints with a matching digital companion. Each artwork boasts its own unique traits, ensuring every piece is one-of-a-kind.
Moreover, Klibansky combines visual art with environmental awareness. For every artwork sold, the partnering non-profit One Tree Planted will plant physical trees in the Amazon. 
In Bodrum between 22-25 August 2024, the art group Random International, a German duo with studios in London and Stockholm, will present an immersive installation that invites visitors to engage physically with a seemingly sentient, digital swarm. Titled ‘When Tomorrow Comes’, the work features a custom tracking system and flocking algorithm to create an interactive digital sculpture blending technology with human perception and interaction. 3 sets of 150 limited signed edition prints of ‘When Tomorrow Comes’ will be available for purchase.
A global name in human-machine collaboration, and multi-award winning Chinese-Canadian artist Sougwen 愫君 Chung will perform a live showcase with the robotic system D.O.U.G. (Drawing Operations Unit Generation at Scorpios Bodrum between 5-8 September 2024. The single scheduled performance during that weekend offers a unique opportunity to experience their groundbreaking collaborative work. Chung’s innovative approach to combining human artistry with AI technology has earned them international acclaim, including a spot on TIME Magazine’s TIME100 AI list as one of the world’s most influential people in AI and the TIME Impact Award 2024.
Accompanying the performance will be the debut of ‘Genesis II: Body Machine’, a collection of unique artworks. The works in ‘Body Machine’ speculate on the future of the robotic form intertwined with the human body. Each bespoke work is generated from the artist’s drawing choreography captured in three dimensions and paired with exclusive signed prints. 
All prints and digital artworks will be available for purchase through Scorpios Collect.
The headline artist events are also supported by a programme of featured AI and visual artists, encompassing music into these collaborative events, they will take place throughout the 2024 summer season in both Mykonos and Bodrum. 
Scorpios Co-Founder Thomas Heyne says: “We use digital art to create holistic experiences. Interaction and immersion enhance the overall experience, taking guests on a journey where they feel inspired. We are excited to welcome Joseph Klibansky, Random International, and Sougwen Chung to this year’s Encounters program, showcasing how AI can teach us about living in harmony with nature.”
WWW.THEHOUSEOFFINEART.COMWWW.SCORPIOS.COMWWW.SCORPIOS.COM/ENCOUNTERSWWW.SCORPIOSCOLLECT.COM
Media contact: Emma-Louise O’Neill; [email protected]; +44 7515 136909 
Photo – https://mma.prnewswire.com/media/2452902/Tree_of_Life_Joesph_Klibanksy_HOFA_Gallery.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/scorpios-summer-cultural-series-redefines-ai–visual-art-in-mykonos–bodrum-302188305.html

Continue Reading

Artificial Intelligence

Two Belgian hospitals live with Sectra’s public cloud service for medical imaging based on Microsoft Azure

Published

on

two-belgian-hospitals-live-with-sectra’s-public-cloud-service-for-medical-imaging-based-on-microsoft-azure

LINKÖPING, Sweden, July 3, 2024 /PRNewswire/ — Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals have begun experiencing the benefits of a cloud service such as improved ability to share resources between the sites and more streamlined workflows.

In the city of Bruges in Belgium, the hospitals AZ Sint Lucas and AZ Sint Jan began their journey to the cloud following a contract with Sectra signed in 2023. As the first in the Benelux countries to adopt Sectra’s enterprise imaging as a fully managed service in the public cloud, these hospitals have now gone live with the service.
One of the main reasons for this shift was the need to streamline operations and enhance collaboration between the two sites. Since 2021, the 23 radiologists and nine trainees of both hospitals have worked together in one single association. Previously, they were unable to work in one environment as they were using two different PACS providers. This made it much harder to collaborate. This need originates from the challenge many hospitals face today of dealing with heavy workloads. 
“With an aging population come increasing needs. We are already experiencing a lack of resources and heavier workload. With more and more exams to report on and a shortage of staff, our radiologists are having a hard time coping with the everyday workload. A state-of-the art communal PACS system could help streamline workflow and improve efficiency,” says Dr. Jesse Marrannes, radiologist at AZ Sint-Jan and main medical responsible for this PACS project.
Bart Thielen, Managing Director, Sectra Benelux, adds: “Healthcare today needs to be able to cope with the increasing need for diagnostics and specialized care. Transitioning to the cloud is the first step for hospitals wanting to use new technology to cope with these challenges, as the service offers the needed scalability and security. Many hospitals also deal with staff shortages when it comes to qualified IT staff. I am very happy to offer a solution that will take away some of the stress and resources usually needed to manage the system.”
He continues: “AZ Sint Jan and AZ Sint Lucas pave the way for the transition to public cloud for medical imaging in the Benelux and I’m excited to follow their journey.”
The service is based on Microsoft Azure and fully managed by Sectra. The hospitals saw the potential of the service helping to relieve burden on their IT staff and resources. “The fact that it is a fully managed service and deployed in the cloud gives us more time to focus on the care of our patients rather than on the maintenance of the IT-system and the storage and accessibility of data,” said Annelies Meyns, Head of ICT Applications at AZ Sint Jan, when the project was initiated.
The implementation process began shortly after the contract was signed, with Sectra closely collaborating with hospital teams to ensure a seamless transition. “Moving everything to the cloud is a monumental task, but Sectra’s commitment made it manageable and efficient,” says Jurryt Laleeuwe, Head of ICT Applications at AZ Sint Lucas.
The cloud service is now fully operational, bringing notable enhancements. “The new system has already enhanced our ability to share resources and collaborate on patient cases. The ability to tailor our workflows has also greatly benefited our radiologists, especially for overarching multidisciplinary team meetings” says Dr. Pieter Vandaele, Head of the Department of Radiology at AZ Sint Lucas.
He continues: “The implementation and experience so far have been very positive, and I look forward to seeing the ongoing benefits of this cloud service.”
Sectra’s enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra’s website to read more about Sectra and why it’s top-ranked in “Best in KLAS.”
About SectraSectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2023/2024 fiscal year totaled SEK 2,964 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra’s website.
For further information, please contact:Dr. Torbjörn Kronander, CEO and President Sectra  AB, 46 (0) 705 23 52 27 Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, 46 (0)708 23 56 10
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/sectra/r/two-belgian-hospitals-live-with-sectra-s-public-cloud-service-for-medical-imaging-based-on-microsoft,c4007517
The following files are available for download:
https://news.cision.com/sectra/i/sectra-s-module-for-breast-imaging,c3315483
Sectra’s module for breast imaging
 

View original content:https://www.prnewswire.co.uk/news-releases/two-belgian-hospitals-live-with-sectras-public-cloud-service-for-medical-imaging-based-on-microsoft-azure-302188707.html

Continue Reading

Artificial Intelligence

Barrington James Announces Strategic Acquisition of S3 Science Recruitment

Published

on

barrington-james-announces-strategic-acquisition-of-s3-science-recruitment

LONDON, July 3, 2024 /PRNewswire/ — Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the transaction were not disclosed.

This strategic acquisition marks a significant milestone for Barrington James, enhancing the company’s commitment to expanding its client-service capabilities and supporting the development of cutting-edge technology. This integration will provide clients with greater access to exceptional talent on both a permanent and temporary basis.
Dan Barrington, CEO of Barrington James, stated: “We are thrilled to acquire S3 and expand our Human Capital services in Life Sciences. This acquisition enhances our offerings across Board and Executive partnerships, Permanent Recruitment, Contract Recruitment, Staffing, OSP, and FSP. S3’s expertise in Clinical and Pre-Clinical specializations, both on a temporary and permanent basis, will perfectly complement Barrington James’ comprehensive Life Science services, from Clinical to Post-Marketing, A.I., and beyond. We are excited to collaborate with Alex Barrie, and his team, and we look forward to significantly growing S3 in the coming years.”
Alex Barrie, Director of Recruitment at S3, stated: “Clients of S3 Science Recruitment can expect a seamless transition, marked by the same dedication to excellence and personalized service they have come to rely on. Like Barrington James, we are deeply committed to delivering exceptional value and support to all our clients. By integrating the strengths of both companies, we are not only maintaining our high standards but also elevating them. The exciting integration of S3 Science into Barrington James enables us to offer an even broader and more comprehensive range of staffing solutions, ensuring that our clients benefit from a superior recruitment experience.”
About Barrington James:
Barrington James is a global, industry-leading recruitment business serving the Pharmaceutical, Biotechnology, and Medical Device sectors. With a global presence and a team of hundreds of specialists, we deliver world-class recruitment solutions to life science companies of all sizes. Leveraging a network of over 6 million industry professionals and advanced AI platforms, our expert consultants provide a personalized approach to global life science recruitment. For more information, please visit barringtonjames.com.
About S3 Science Recruitment:
S3 Science Recruitment connects talented individuals with leading organizations and institutions across the UK, Europe, and the United States. Our mission is to enable groundbreaking discoveries and life-saving treatments today. Specializing in drug discovery, medical research, and the broader Life Sciences field, we support the UK’s leadership in developing cures and treatments. Since 2002, S3 Science Recruitment has helped Life Sciences organizations find passionate individuals dedicated to medical advancement, particularly in animal research. We believe attracting talent to this vital industry is just the beginning of greater achievements. For more information, please visit s3science.com.
CONTACT: Amy TilburyHead of [email protected]+44 (0) 1293 776644
Photo – https://mma.prnewswire.com/media/2452929/Barringtonjames.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/barrington-james-announces-strategic-acquisition-of-s3-science-recruitment-302188155.html

Continue Reading

Trending